Paul M. Ridker, MD, MPH, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(SIGNIFICANT), Civi Biopharm(SIGNIFICANT), Agepha(SIGNIFICANT), AstraZeneca(MODEST), Flame, Inc(SIGNIFICANT), Sirnanomics(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Omeicos(SIGNIFICANT), IQVIA(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Health Outlook(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Uppton, Ltd(NONE) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), National Heart Lung and Blood Institute (NHLBI)(SIGNIFICANT), Kowa Pharmaceuticals (SIGNIFICANT), Amarin(SIGNIFICANT)

View Full Disclosure